Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.49 CAD | -1.32% | -5.10% | -16.76% |
15/05 | Transcript : Oncolytics Biotech Inc. - Shareholder/Analyst Call | |
15/05 | Oncolytics Biotech Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Pancreatic Cancer Trial | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.76% | 8.27Cr | |
+59.67% | 6.26TCr | |
-2.76% | 4.12TCr | |
+44.70% | 4.03TCr | |
-8.29% | 2.79TCr | |
+12.94% | 2.62TCr | |
-21.99% | 1.91TCr | |
+5.87% | 1.31TCr | |
+24.86% | 1.23TCr | |
+27.45% | 1.21TCr |
- Stock Market
- Equities
- ONC Stock
- News Oncolytics Biotech Inc.
- Oncolytics Biotech Inc. Announces Resignation of Brad Thompson from Board of Directors